Candriam SCA’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-11,019
Closed -$857K 697
2023
Q4
$857K Hold
11,019
0.01% 604
2023
Q3
$775K Hold
11,019
0.01% 589
2023
Q2
$878K Sell
11,019
-14,634
-57% -$1.06M 0.01% 623
2023
Q1
$1.71M Sell
25,653
-1,471
-5% -$115K 0.01% 608
2022
Q4
$2.23M Buy
27,124
+4,694
+21% +$387K 0.02% 559
2022
Q3
$1.75M Buy
+22,430
New +$1.79M 0.01% 607
2018
Q1
Sell
-15,000
Closed -$489K 761
2017
Q4
$489K Buy
15,000
+5,000
+50% +$173K 0.01% 680
2017
Q3
$478K Buy
+10,000
New +$487K 0.01% 660

Other funds holding ACHC

Candriam SCA's ACHC Position: Q1 2024 in Review

Candriam SCA sold out of Acadia Healthcare (ACHC) in Q1 2024, closing a stake of 11,019 shares — an estimated $857K sold.

Candriam SCA first reported a position in ACHC in Q3 2017 and held it in 8 quarters. The position peaked at $2.23M in Q4 2022. 322 funds tracked by Wall St. Rank hold ACHC as of Q1 2024.

  • Candriam SCA reported no remaining Acadia Healthcare position as of Q1 2024 after selling out during the quarter.
  • Candriam SCA sold 11,019 Acadia Healthcare shares in Q1 2024, an estimated $857K.
  • Candriam SCA first reported a position in Acadia Healthcare in Q3 2017 and held it in 8 quarters.
  • Candriam SCA's Acadia Healthcare position peaked at $2.23M in Q4 2022.
  • 322 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2024.

Based on Candriam SCA's 13F filing for Q1 2024, filed 6 May 2024.